Metastatic Uveal Melanoma (UM)

Also known as: Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic / Metastatic Uveal Melanoma

DrugDrug NameDrug Description
DB15283TebentafuspA bispecific gp100 peptide-HLA-directed CD3 T cell engager used to treat unresectable or metastatic uveal melanoma.
DrugDrug NameTargetType
DB15283TebentafuspMelanocyte protein PMELtarget
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin1Recruiting1
DB00112Bevacizumab1Recruiting1
DB00531Cyclophosphamide1Recruiting2
DB14999Human interferon beta1Suspended1
DB14865Human interleukin-21Not Yet Recruiting1
DB06186Ipilimumab1Recruiting1
DB01042Melphalan1Not Yet Recruiting1
DB09035Nivolumab1Recruiting1
DB01229Paclitaxel1Recruiting1
DB11182Rose bengal1Recruiting1
DB16626Tyrosinase1Suspended1
DB05531alpha-Pyrrolidinononanophenone1Recruiting1
DB11967Binimetinib1 / 2Recruiting1
DB08865Crizotinib1 / 2Recruiting1
DB16059IDE-1961 / 2Recruiting1
DB06186Ipilimumab1 / 2Recruiting1
DB01042Melphalan1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00041Aldesleukin2Terminated1
DB05015Belinostat2Recruiting1
DB11967Binimetinib2Recruiting1
DB00262Carmustine2Recruiting1
DB00531Cyclophosphamide2Terminated1
DB00851Dacarbazine2Completed1
DB12282Defactinib2Recruiting1
DB11841Entinostat2Active Not Recruiting1
DB00965Ethiodized oil2Recruiting1
DB01073Fludarabine2Terminated1
DB06186Ipilimumab2Active Not Recruiting2
DB09078Lenvatinib2Not Yet Recruiting1
DB09035Nivolumab2Active Not Recruiting2
DB09035Nivolumab2Recruiting1
DB09035Nivolumab2Terminated1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Not Yet Recruiting1
DB15254RO-5126766 free base2Recruiting1
DB14851Relatlimab2Recruiting1
DB01268Sunitinib2Completed1
DB08911Trametinib2Withdrawn1
DB00577Valaciclovir2Terminated1
DB02546Vorinostat2Active Not Recruiting1